Arbeitsgemeinschaft |  | Association for |
> Annual Meeting > Annual Meetings - Übersicht > Annual Meeting 2009 > Präsentationen 2009
Präsentationen des Joint Meetings 2009
Bélorgey, Ch.
Current European Experience with trial approval in early development: Afssaps (France)French_experience_Ch_Belorgey.pdf (151 kB)
Bone, M.
Research Ethics Review in The UK: Improving the process with a focus on the Integrated Research Application System (IRAS)Bone___Ethics_review_UK_AAHP_Lyon.pdf (2 MB)
Chassard, D.
Drug-Drug interactions. Update on the Study DesignPraes._Chassard_DDI_DC_30MAR09__2_.pdf (371 kB)
Cortez, P.
Immunogenicity of Biological productsWorkshop_AGAH_Club_Phase_I_P_Cortez_version_pour_edition_May2009.pdf (986 kB)
de Zeeuw, R.
Trial Approval in Early Drug Development: Current Experiences in The NetherlandsPresentation_Lyon_Rokus_de_Zeeuw.pdf (78 kB)
Donazzolo, Y. & Tremblay, D.
Exploratory clinical trials workshopExploratory_trials_DTremblay_YDonazzolo.pdf (173 kB)
Janssens, W.
Timelines, missing aspects in dossiers, reasons for delays, questions to applicants, how to improve the processBelgium_experience_W_Janssens.pdf (406 kB)
Mant, T.
Translational Medicine: Dream or Nightmare?Translational_Dream_or_Nightmare_TMant.pdf (2 MB)
Patat, A.
Accrediation of Phase I Units and protection of the subjects participating in clinical trials in FranceFrance_CPU_Accreditation_APatat.pdf (77 kB)
Patat, A., Sibille, M., Caplain, H., Donazzolo, Y., Chalon, S.
Stopping rules in First entry into human studiesStopping_rules_APatat_MSibille.pdf (696 kB)
Sibille, M. & Hinze, C.
Serious adverse events in Phase I: French and German SAE RegistersFrench_and_German_SAE_Registers_MSibille_CHinze.pdf (1 MB)
Taubel, J.
Managing the risk of Phase I trials: Accreditation of Phase I Units in the UKUK_CPU_Accreditation_JTaubel.pdf (223 kB)
Thomsen, T.
Managing challenges in early drug development: Biologicals and small moleculesGermany_CPU_Accreditation_TThomsen.pdf
Seite aktualisiert am 21.05.2009
